Akebia Therapeutics's total assets for Q4 2025 were $376.56M, an increase of 3.41% from the previous quarter. AKBA total liabilities were $343.95M for the fiscal quarter, a 6.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.